Collegium Pharmaceutical, Inc. Gross Profit 2013–2025
Collegium Pharmaceutical, Inc. reported $463.26M of gross profit for fiscal 2025. That was 22.8% higher than fiscal 2024. Compared with fiscal 2020, the change was +157.6%.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $463.26M | 59.3% | +22.8% |
| FY 2024 | $377.34M | 59.8% | +15.7% |
| FY 2023 | $326.17M | 57.5% | +55.7% |
| FY 2022 | $209.49M | 45.2% | +39.1% |
| FY 2021 | $150.62M | 54.4% | -16.2% |
| FY 2020 | $179.84M | 58.0% | +74.5% |
| FY 2019 | $103.04M | 34.7% | -10.2% |
| FY 2018 | $114.74M | 40.9% | +343.3% |
| FY 2017 | $25.88M | 90.9% | +1627.7% |
| FY 2016 | $1.50M | 87.6% | — |
| FY 2015 | — | — | — |
| FY 2014 | — | — | — |
| FY 2013 | — | — | — |
Source: Collegium Pharmaceutical, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open COLL 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Collegium Pharmaceutical, Inc. reported $463.26M of gross profit for fiscal 2025. That was 22.8% higher than fiscal 2024. Compared with fiscal 2020, the change was +157.6%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Collegium Pharmaceutical, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCollegium Pharmaceutical, Inc. — frequently asked questions
What is Collegium Pharmaceutical, Inc.'s gross profit?
Collegium Pharmaceutical, Inc. (COLL) reported gross profit of $463.26M for fiscal year 2025, per its SEC filings.
How has Collegium Pharmaceutical, Inc.'s gross profit changed over time?
Between fiscal 2013 and 2025, COLL's gross profit grew at roughly 61.3% per year (compound annual rate), from $1.50M to $463.26M.
Where does this data come from?
Figures are computed from Collegium Pharmaceutical, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.